Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients

Journal of Clinical Investigation

Volumn 92, Issue 3, 1993, Pages 1436-1443

  Fukuda, Naoko ^b   Tanaka, Hiroyuki ^b   Tominaga, Yoshihiro ^b   Fukagawa, Masafumi ^b   Kurokawa, Kiyoshi ^b   Seino, Yoshiki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Calcitriol receptor; Chronic renal failure; Hyperparathyroidism; Immunohistochemistry; Vitamin D resistance

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG RESISTANCE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PRIORITY JOURNAL; RECEPTOR DENSITY; SECONDARY HYPERPARATHYROIDISM; UREMIA;

CHRONIC DISEASE; HUMAN; HYPERPARATHYROIDISM; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; PARATHYROID HORMONES; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; SUPPORT, NON-U.S. GOV'T; UREMIA;

EID: 0027217909     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116720     Document Type: Article

References (36)

1. Coburn, J. W., and E. A. Slatopolsky. 1991. The renal osteodystrophy. In The Kidney. B. M. Brenner and F. C. Rector, editors. W. B. Saunders Company, Philadelphia, p. 2058.
2. Fukagawa, M., S. Kaname, T. Igarashi, E. Ogata, and K. Kurokawa. 1991. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int. 39:874-881.
3. 3 in the parathyroid glands of patients with renal failure. N. Engl. J. Med. 316:1573-1577.
4. 3 receptor in experimental uremia. Kidney Int. 32:350-353.
5. 2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int. 35:19-23.
6. Shvil, Y., T. Naveh-Many, P. Barach, and J. Silver. 1990. Regulation of parathyroid cell gene expression in experimental uremia. J. Am. Soc. Nephrol. 1:99-104.
7. 9k in uraemic rats. Eur. J. Clin. Invest. 21:521-526.
8. Krause, M. W., and C. E. Hedinger. 1985. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum. Pathol. 16:772-784.
9. Akerstrom, G., J. Malmaeus, L. Grimelius, S. Ljunghall, and R. Bergstrom. 1984. Histological changes in parathyroid glands in subclinical and clinical renal disease. An autopsy investigation. Scand. J. Urol. Nephrol. 18:75-84.
10. Malmaeus, J., L. Grimelius, H. Johansson, G. Akerstrom, and S. Ljunghall. 1984. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. Scand. J. Urol. Nephrol. 18:157-166.
11. Tominaga, Y., H. Takagi, H. Suzuki, and T. Kondo. 1985. Histopathological study of parathyroid gland in renal hyperparathyroidism. J. Jpn. Surg. Soc. 86:630-639.
12. Tominaga, Y., Y. Tanaka, K. Sato, M. Numao, K. Uchida, U. Falkmer, L. Grimelius, H. Johansson, and H. Takagi. 1992. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J. Surg. 16:595-603.
13. 3. J. Biol. Chem. 259:1167-1173.
14. Sone, T., D. P. McDonnell, B. W. O'Malley, and W. Pike. 1990. Expression of human vitamin D receptor in Saccharomyces. J. Biol. Chem. 265:21997-22003.
15. Finch, J. L., N. Rapp, K. J. Martin, and E. Slatopolsky. 1992. A new sensitive homologous radioimmunoassay for amino-terminal parathyroid hormone in the rat. J. Bone Miner. Res 7:229-233.
16. Hellman, P., G. Akerstrom, S. Ljunghall, and J. Rastad. 1989. Surgical findings and results of subtotal and total parathyroidectomy in hypercalcemic patients with uremic hyperparathyroidism. Acta Chir. Scand. 155:573-582.
17. Takagi, H., Y. Tominaga, K. Uchida, N. Yamada, K. Kawasaki, and H. Suzuki. 1983. Polymorphism of parathyroid glands in patients with chronic renal failure and secondary hyperparathyroidism. Endocrinol. Jpn. 30:463-468.
18. Tominaga, Y., L. Grimelius, U. G. Falkmer, H. Johansson, and S. Falkmer. 1991. DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse. Anal. Cell Pathol. 3:325-333.
19. Slatopolsky, E., C. Weerts, J. Thielan, R. Horst, H. Harter, and K. J. Martin. 1984. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J. Clin. Invest. 74:2136-2143.
20. Chan, Y. L., C. McKay, E. Dye, and E. Slatopolsky. 1986. The effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells. Calcif. Tissue. Int. 38:27-32.
21. Delmez, J. A., C. Tindira, P. Grooms, A. Dusso, D. W. Windus, and E. Slatopolsky. 1989. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J. Clin. Invest. 83:1349-1355.
22. Dunlay, R., M. Rodriguez, A. J. Felsenfeld, and F. Llach. 1989. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 36:1093-1098.
23. Heinrich, G., H. M. Kronenberg, and J. T. Potts. 1983. Parathyroid hormone messenger ribonucleic acid: effect of calcium on cellular regulation in vitro. Endocrinology 112:449-458.
24. Silver, J., J. Russell, and L. M. Sherwood. 1985. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid cells. Proc. Natl. Acad. Sci. USA. 82:4270-4273.
25. 3 suppresses PTH secretion from bovine parathyroid cells in tissue culture. Endocrinology. 227:2114-2119.
26. 3 of transcription of the parathyroid hormone gene. Endocrinology. 119:2864-2866.
27. Silver, J., T. Naveh-Many, H. Mayer, H. J. Schmelzer, and M. M. Popovtzer. 1986. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest. 78:1296-1301.
28. 3. J. Biol. Chem. 263:2203-2208.
29. 3 inhibits hormone secretion and proliferation but not functional differentiation of cultured bovine parathyroid cells. Calcif. Tissue Int. 43:213-218.
30. Kremer, R., I. Bolivar, D. Goltzman, and G. N. Hendy. 1989. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology. 125:935-941.
31. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int. 35:1049-1056.
32. Falchetti, A., A. E. Bale, A. Amorosi, C. Bordi, P. Cicchi, S. Bradini, S. J. Marx, and M. L. Brandi. 1993. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J. Clin. Endocrinol. & Metab. 76:139-144.
33. Arnold, A., M. Brown, P. Urena, T. Drueke, and E. Sarfati. 1992. X-inactivation analysis of clonality in primary and secondary parathyroid hyperplasia. (Abstr.) J. Bone Miner. Res. 7(Suppl. 1):241.
34. Wallfelt, C. H., R. Larsson, E. Gylfe, S. Ljunghall, J. Rastad, and G. Akerstrom. 1988. Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation. World J. Surg. 12:431-438.
35. Juhlin, C., J. Rastad, L. Klareskog, L. Grimelius, and G. Akerstrom. 1989. Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am. J. Pathol. 135:321-328.
36. Kitaoka, M., M. Fukagawa, Y. Tanaka, E. Ogata, and K. Kurokawa. 1991. Parathyroid gland size is critical for long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. (Abstr.) J. Am. Soc. Nephrol. 2:637.